MedPath

Temple University-of the Commonwealth System of Higher Education

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Phase 2
Completed
Conditions
Lymphoma
First Posted Date
2003-01-27
Last Posted Date
2010-10-01
Lead Sponsor
Temple University
Registration Number
NCT00002522
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Fox Chase - Temple Cancer Center, Philadelphia, Pennsylvania, United States

High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis

Phase 2
Completed
Conditions
Multiple Myeloma and Plasma Cell Neoplasm
First Posted Date
2003-01-27
Last Posted Date
2010-10-01
Lead Sponsor
Temple University
Registration Number
NCT00002810
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Fox Chase-Temple Cancer Center CCOP Research Base, Philadelphia, Pennsylvania, United States

Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma

Phase 2
Completed
Conditions
Lymphoma
First Posted Date
2003-01-27
Last Posted Date
2010-10-01
Lead Sponsor
Temple University
Registration Number
NCT00002521
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Fox Chase - Temple Cancer Center, Philadelphia, Pennsylvania, United States

Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer

Phase 2
Completed
Conditions
Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Diseases
First Posted Date
2003-01-27
Last Posted Date
2010-10-01
Lead Sponsor
Temple University
Target Recruit Count
10
Registration Number
NCT00002809
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Fox Chase-Temple Cancer Center, Philadelphia, Pennsylvania, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath